No black box warning on record for Guaifenesin Syrup And Dextromethorphan

As of the latest FDA labeling reviewed, Guaifenesin Syrup And Dextromethorphan (GUAIFENESIN SYRUP AND DEXTROMETHORPHAN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Guaifenesin Syrup And Dextromethorphan medicine page for the complete safety profile.

Other warnings & precautions

Warnings Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) or for two weeks after stopping the MAOI drug. Ask a doctor before use if you have • cough that occurs with too much phlegm (mucus) • cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis or emphysema Ask a doctor or pharmacist before use if you are taking any other drug Sto

No black box warning on record for Guaifenesin Syrup And Dextromethorphan

Other warnings & precautions

Warnings Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) or for two weeks after stopping the MAOI drug. Ask a doctor before use if you have • cough that occurs with too much phlegm (mucus) • cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis or emphysema Ask a doctor or pharmacist before use if you are taking any other drug Sto

Guaifenesin Syrup And Dextromethorphan Black Box Warning

No black box warning on record for Guaifenesin Syrup And Dextromethorphan

Other warnings & precautions

Guaifenesin Syrup And Dextromethorphan Black Box Warning

No black box warning on record for Guaifenesin Syrup And Dextromethorphan

Other warnings & precautions